How to Get a Rapamycin Prescription for Longevity (What Doctors Actually Want to See)

The Drug Everyone in Longevity Circles Is Talking About

Walk into any serious longevity conference, open any longevity-focused subreddit, or scroll through the feeds of people like Bryan Johnson or Peter Attia, and rapamycin comes up. Not occasionally. Constantly. It's been called the most promising longevity drug we currently have access to, and unlike most things that earn that label, there's actually a decent pile of evidence behind it — at least in animal models, and increasingly in humans.

But here's the thing most people discover pretty quickly: rapamycin isn't something you just order online. It's a prescription drug, and most conventional doctors won't touch the longevity use case with a ten-foot pole. So the question most people end up asking isn't "does rapamycin work?" It's: how do I actually get a rapamycin prescription?

This article answers that question in full. You'll learn what doctors look for before prescribing it, which labs to bring, how off-label prescribing works, what the risks actually are, and how telehealth clinics like Healthspan handle the whole process. No hype, no hand-waving. Just the practical information you need to figure out if this is right for you.

What Is Rapamycin, Really?

Rapamycin (generic name: sirolimus) was discovered in 1972 in soil samples from Easter Island — Rapa Nui, hence the name. It was originally developed as an antifungal, then repurposed as an immunosuppressant for organ transplant patients. The longevity angle came later, somewhat by accident, when researchers noticed that mice given rapamycin late in life lived significantly longer than controls.

The mechanism is elegant. Rapamycin inhibits a protein complex called mTOR (mechanistic target of rapamycin), which acts like a cellular growth thermostat. When mTOR is highly active, your cells are in full growth-and-production mode. When mTOR is dialed back, your cells shift into a kind of maintenance mode: clearing out damaged proteins, repairing cellular machinery, and doing the housekeeping that gets neglected when growth is the priority. Think of mTOR inhibition as telling your cells to pause the factory floor and fix the machines instead of running them at full speed.

That maintenance mode has a name: autophagy. And it's one of the primary reasons rapamycin is so interesting for longevity research. Dysfunctional autophagy is implicated in Alzheimer's, cancer, cardiovascular disease, and the general cellular decline we associate with aging.

At transplant doses, rapamycin suppresses the immune system significantly. That's why your average GP won't prescribe it casually. At the intermittent, low doses used in longevity protocols, the immune suppression is far more modest, and some research actually suggests immune enhancement in older adults. But the distinction between transplant dosing and longevity dosing is critical, and it's one of the things any prescribing doctor will think carefully about.

How Off-Label Prescribing Works

Here's something that surprises a lot of people: off-label prescribing is completely legal and extremely common in the United States. The FDA approves drugs for specific indications, but once a drug is approved, physicians can prescribe it for any use they judge to be medically appropriate. Rapamycin is FDA-approved for organ transplant rejection and certain rare diseases. Prescribing it for longevity is off-label, but not illegal or even unusual in longevity-focused practices.

The catch is liability and training. Most primary care physicians don't have familiarity with the longevity dosing literature, aren't comfortable with the risk profile in a healthy patient, and frankly don't have time to get up to speed. So they say no. That's not negligence — it's reasonable caution given their context.

Longevity-focused clinicians, on the other hand, have made it their job to understand this literature. They've read the ITP (Interventions Testing Program) data, they've followed the PEARL trial and the ongoing human studies, they understand the difference between 2mg daily in a transplant patient and 5mg once a week in a healthy 50-year-old, and they know what to monitor. That's the difference between a flat "no" from your GP and a thoughtful "let's look at your labs" from a longevity physician.

What Doctors Look for Before Writing a Rapamycin Prescription

If you're going to approach a physician about a rapamycin prescription, it helps to know what they're actually evaluating. Here's what any careful prescriber is thinking about:

Your overall health baseline

Rapamycin is not a fix for underlying disease — it's a longevity tool for people who are already in reasonably good health and want to stay that way. Most longevity clinicians want to see that you're not dealing with active infections, untreated metabolic dysfunction, or conditions that could be complicated by mTOR inhibition.

Cardiovascular and metabolic markers

Rapamycin can affect lipids. Specifically, it can raise triglycerides and LDL in some patients. A prescribing physician will want a baseline lipid panel before starting, and will watch for changes. If your triglycerides are already elevated, that's a conversation — not necessarily a disqualifier, but something that needs to be addressed.

Blood glucose and insulin sensitivity

mTOR plays a role in insulin signaling, and high-dose rapamycin can worsen insulin resistance. At low, intermittent longevity doses the effect appears to be minimal or even favorable, but a doctor will still want fasting glucose and HbA1c as a baseline, especially if you have any history of pre-diabetes.

Immune status

If you have an active infection, are immunocompromised for another reason, or are taking immunosuppressants, rapamycin adds complexity. A CBC (complete blood count) gives a window into immune function and is standard on any baseline panel.

Kidney and liver function

Rapamycin is metabolized in the liver (via CYP3A4, the same enzyme that processes grapefruit juice, among many other things). A basic metabolic panel covering creatinine, BUN, and liver enzymes is essential. Certain drug interactions through this pathway are also clinically relevant — your prescriber will want a full medication list.

Your goals and risk tolerance

A good longevity clinician isn't just running numbers — they're having a conversation. Why do you want this? What are your health goals? Do you understand this is off-label and the long-term human data is still emerging? That conversation matters as much as the labs.

Which Labs to Bring (or Get Ordered)

If you're walking into a consultation, bringing recent labs speeds everything up and signals that you're a serious, engaged patient. Here's what a typical rapamycin pre-prescription workup looks like:

• Complete Metabolic Panel (CMP): kidney function (creatinine, BUN), liver enzymes (ALT, AST), electrolytes, glucose
• Lipid Panel: total cholesterol, LDL, HDL, triglycerides — ideally with ApoB if available
• HbA1c and fasting insulin: baseline insulin sensitivity markers
• Complete Blood Count (CBC): immune cell status, red blood cell health
• hsCRP: high-sensitivity C-reactive protein, a marker of systemic inflammation
• Testosterone (for men) or hormone panel (for women): relevant to overall health context
• Thyroid (TSH at minimum): thyroid dysfunction can affect how you respond to metabolic interventions

Labs under 3-6 months old are generally acceptable. Older than that and you'll likely need a fresh draw before anything gets prescribed.

What the Evidence Actually Shows

Let's be honest about where the science stands. The longevity case for rapamycin is built on a strong animal foundation and early but promising human data — not yet a stack of large randomized controlled trials in healthy adults.

The animal data is legitimately impressive

The ITP — a rigorous, multi-site program funded by the National Institute on Aging — found that rapamycin extended median lifespan in mice by 9-14%, even when started late in life (the equivalent of giving it to a 60-year-old human). This has been replicated across multiple labs with different mouse strains. That kind of consistency in animal research is unusual and meaningful.

The human immune data is interesting

A 2014 study by Mannick et al. found that a rapamycin analog (everolimus) improved vaccine response in elderly subjects by up to 20% — suggesting immune enhancement rather than suppression at low doses. This is a counter-intuitive finding that's still being explored, but it's one of the reasons researchers are cautiously optimistic about low-dose intermittent protocols in older adults.

The PEARL trial is ongoing

The first dedicated human longevity trial of rapamycin in healthy older adults is underway. We don't have results yet. That's not a reason to dismiss rapamycin, but it is a reason to approach it with calibrated expectations rather than certainty.

You are not a mouse

This needs to be said. Mouse metabolism differs from human metabolism in significant ways. Dosing that produces dramatic results in rodents doesn't always translate cleanly to humans. The animal data gives us a strong mechanistic rationale and a reason to take rapamycin seriously. It doesn't prove that a 45-year-old human who takes 5mg weekly will live longer. Nobody knows that yet.

The Reality Check: What's Hyped vs. What's Real

The internet loves rapamycin right now. You'll find people swearing it cleared their brain fog, improved their sleep, and made them feel 15 years younger. Some of that may be real. Some of it is placebo. Some of it is the general effect of working with a physician who's paying attention to your health for the first time in years.

What's real: the mechanism is legitimate, the animal evidence is strong, the early human data is encouraging, and the risk profile at low intermittent doses appears manageable for healthy adults. What's still uncertain: long-term effects in humans, optimal dosing protocols, who benefits most, and whether the lifespan extension seen in mice translates to people. Promising, but still evolving. That's the honest position.

Who Is a Rapamycin Prescription Actually Right For?

Rapamycin for longevity isn't for everyone, and any honest clinician will tell you that. Here's the profile of someone who's a reasonable candidate:

• Generally healthy adults, typically 40+, with no active infections or serious immunocompromising conditions
• Metabolically healthy or well-managed: normal or near-normal glucose, lipids that aren't severely dysregulated
• Not on medications that interact heavily with CYP3A4 pathways
• Interested in proactive longevity, not looking for a treatment for a current condition
• Comfortable with the off-label nature and the fact that human long-term data is still emerging
• Willing to get baseline labs and follow up regularly

If you're dealing with active health conditions, are immunocompromised, or are looking for a quick fix, rapamycin is not the right starting point. If you're a relatively healthy person in middle age or beyond who wants to be proactive about aging, it's worth a serious conversation.

Risks and Side Effects: What to Know

At low, intermittent longevity doses, serious side effects are uncommon — but they're not zero. Here's what the clinical picture looks like:

• Mouth sores (aphthous ulcers): the most commonly reported side effect, usually mild and often dose-dependent. Reducing the dose or using a mouth rinse typically resolves it.
• Lipid changes: triglycerides and LDL can increase in some individuals. Monitoring lipids every few months lets you catch this early.
• Infection risk: at transplant doses, infection risk is significant. At longevity doses, the risk is much lower, but it's still sensible to pause rapamycin if you have an active infection, are getting a live vaccine, or are going in for surgery.
• Delayed wound healing: mTOR inhibition can slow tissue repair. Again, pausing around surgeries or injuries is standard protocol.
• Insulin signaling effects: possible in some individuals, especially at higher doses. Baseline and periodic glucose monitoring handles this.
• Drug interactions: the CYP3A4 pathway means interactions with certain antifungals, antibiotics, and some supplements (notably grapefruit). Your prescriber needs your full medication and supplement list.

The takeaway: this is a drug that needs medical supervision. The side effects at longevity doses are generally manageable, but "generally" is doing work there. Monitoring is what makes the difference between a protocol and a gamble.

How to Actually Get a Rapamycin Prescription Through Healthspan

This is where the practical rubber meets the road. Getting a rapamycin prescription through a conventional GP is an uphill battle in most cases. Longevity-focused telehealth clinics exist precisely because there's a gap between what the evidence supports and what conventional medicine is set up to offer.

Healthspan's The Rapamycin Protocol is designed to handle the entire process in a medically rigorous way. Here's what it actually includes:

• A clinical consultation with a physician who specializes in longevity medicine and understands the off-label literature. This isn't a five-minute checkbox — it's a real conversation about your health history, goals, and whether rapamycin is appropriate for you.
• Lab review: you can bring existing labs or get new ones ordered. The physician will review your metabolic panel, lipids, glucose, CBC, and anything else relevant before making a prescribing decision.
• Individualized dosing: longevity protocols typically start at 2-5mg once weekly, but the right starting dose depends on your health profile. Your physician will recommend a specific protocol based on your labs and history, not a one-size-fits-all approach.
• Ongoing monitoring: follow-up labs and physician check-ins to monitor lipids, glucose, and any side effects. Dose adjustments as needed. This is the part most people miss when they think about getting rapamycin online — a prescription without monitoring is incomplete care.

If you're also interested in complementary longevity interventions, Healthspan offers additional protocols that pair well with rapamycin. Longevity Optimization provides a broader framework for proactive longevity care, while Metformin is another well-studied, off-label longevity drug that some physicians combine with rapamycin for additive effects on metabolic health. And if you're curious about rapamycin's topical applications (there's a separate body of evidence on skin aging), Topical Rapamycin for Skin is another option worth exploring.

The right next step: book a consultation with a Healthspan physician to review your labs and determine whether The Rapamycin Protocol is a fit for you.

Frequently Asked Questions About Getting a Rapamycin Prescription

Can my regular doctor prescribe rapamycin for longevity?

Technically yes — off-label prescribing is legal in the US. Practically, most primary care physicians will decline because they're not familiar with the longevity dosing literature and aren't comfortable with the liability. Your best path is a physician who specializes in longevity medicine and has experience with rapamycin protocols specifically.

What dose of rapamycin is used for longevity?

Most longevity protocols use 2-6mg once weekly, compared to the daily doses of 2-5mg used in transplant patients. The intermittent dosing is deliberate — it's designed to produce cyclic mTOR inhibition while allowing recovery of immune function between doses. Your specific dose should be determined by a physician based on your labs and health profile.

How long does it take to get a rapamycin prescription through Healthspan?

After your initial consultation and lab review, prescriptions are typically issued within a few days if you're a good candidate. If labs are needed, add the time for a blood draw and results. The whole process from first consultation to first prescription is usually under two weeks.

Is rapamycin safe for long-term use at longevity doses?

The honest answer is we don't have decades of long-term data in healthy humans at longevity doses. What we have: strong animal evidence, short-to-medium-term human data showing manageable side effect profiles at low weekly doses, and a growing community of longevity physicians who have prescribed it for several years with close monitoring. It appears safe for many people — but it's not proven safe indefinitely, and ongoing monitoring matters.

Do I need labs before getting a rapamycin prescription?

Yes, and this is non-negotiable at any responsible clinic. At minimum you need a metabolic panel (kidney and liver function), lipid panel, glucose and HbA1c, and CBC. These establish your baseline so your physician can catch any adverse changes early. Bring labs less than 3-6 months old or plan for a fresh draw.

Can rapamycin be combined with other longevity drugs like metformin?

Some longevity physicians do prescribe rapamycin alongside metformin, as both target aging-related pathways (mTOR and AMPK, respectively) and may have complementary effects. The combination has been studied in animals with positive results. In humans, it requires careful clinical judgment — your physician needs to know your full picture before recommending a combination protocol.

What happens if rapamycin causes side effects?

The most common side effect is mouth sores, which are usually mild and often respond to dose reduction. For lipid changes or other metabolic effects, your physician can adjust the dose or add targeted interventions. If you're working with a supervised protocol, you have a physician to call when something comes up — which is exactly why unsupervised use is a bad idea.